Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancerCharles E. Geyer, Tanja Španić, Judy E. Garber et al.|Annals of Oncology|2022Cited by 461
Preliminary monocentric results of biological characteristics of pregnancy associated breast cancerSilvia Michieletto, Fernando A. Bozza, R. Grigoletto et al.|The Breast|2013Cited by 17